Fadi_Hariri_Chercheur_Étoile

Fadi Hariri, Ph.D. student in Molecular Biology, Systems Biology option, at the IRIC

Mr. Fadi Hariri, PhD student in Molecular Biology, Systems Biology option, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal received the Étudiants-chercheurs étoiles Award of the Fonds de recherche du Québec, Health Funds, for the month of August. This competition comes with a prize of $1 000.

Rewarded for his publication “The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-kB and is aberrantly regulated in acute myeloid leukemia” published in Leukemia, his research about the structure and function of the cell nucleus in Kathy Borden’s team aims to understand the dysregulation role of the eIF4E protein in acute myeloid leukemia (AML) and other cancer subtypes.

“Fadi fully deserves this award. This study will allow a potential development of innovative therapies for AML patients” said Dr. Katherine Borden, Principal Investigator at IRIC and Professor at the Department of Pathology and Cell Biology, Faculty of Medicine.

Study cited

The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.
Hariri F, Arguello M, Volpon L, Culjkovic-Kraljacic B, Nielsen TH, Hiscott J, Mann KK, Borden KL
Leukemia 2013;27(10):2047-55

About the Étudiants-chercheurs étoiles Award from the Fonds de recherche du Québec

The competition aims to recognize the exceptional research contributions of college and university students, postdoctoral fellows and members of professional bodies who are enrolled in advanced research training programs in the areas covered by the three Fonds de recherche du Québec. For more information: www.frq.gouv.qc.ca

About the Institute for Research in Immunology and Cancer

An ultra-modern research hub and training centre located in the heart of the Université de Montreal, the Institute for Research in Immunology and Cancer (IRIC) was created in 2003 to shed light on the mechanisms of cancer and discover new, more effective therapies to counter this disease. IRIC operates according to a model that is unique in Canada. Its innovative approach to research has already led to discoveries that will, over the coming years, have a significant impact on the fight against cancer. For more information: www.iric.ca